Effect of long-term hormone therapy on telomere length in postmenopausal women.
about
Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy useEmployment and work schedule are related to telomere length in womenSex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cellsGenetic variation in telomere maintenance genes, telomere length and breast cancer riskTrajectories and phenotypes with estrogen exposures across the lifespan: What does Goldilocks have to do with it?Danazol Treatment for Telomere DiseasesCritically short telomeres and toxicity of chemotherapy in early breast cancerCognitive performance and leukocyte telomere length in two narrow age-range cohorts: a population studyDo US Black Women Experience Stress-Related Accelerated Biological Aging?: A Novel Theory and First Population-Based Test of Black-White Differences in Telomere Length.Examining the gender difference in the association between metabolic syndrome and the mean leukocyte telomere lengthCognitive effects of cancer systemic therapy: implications for the care of older patients and survivors.Telomeres and immunological diseases of agingGreater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline.Telomere length and recurrence risk after curative resection in patients with early-stage non-small-cell lung cancer: a prospective cohort study.Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future researchA system-level pathway-phenotype association analysis using synthetic feature random forest.The effects of 17-β estradiol on enhancing proliferation of human bone marrow mesenchymal stromal cells in vitro.Short telomeres in short-lived males: what are the molecular and evolutionary causes?Leukocyte telomere length and its association with mammographic density and proliferative diagnosis among women undergoing diagnostic image-guided breast biopsy.Candidate mechanisms for chemotherapy-induced cognitive changes.Differential Telomere Shortening in Blood versus Arteries in an Animal Model of Type 2 Diabetes.Social relationships and health: is feeling positive, negative, or both (ambivalent) about your social ties related to telomeres?Paternal age at birth is associated with offspring leukocyte telomere length in the nurses' health study.Biomarkers for cognitive aging part I: telomere length, blood pressure and cognition among individuals with hypertensionTelomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO studyCytomegalovirus is associated with reduced telomerase activity in the Whitehall II cohortTelomere length and reproductive aging.Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?Is telomere length a biomarker of aging? A review.Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.Telomere length and cardiovascular aging.Relationships of sex hormone levels with leukocyte telomere length in Black, Hispanic, and Asian/Pacific Islander postmenopausal women.Association between telomere length and diabetes mellitus: A meta-analysis.Leukocyte telomere length and mortality among U.S. adults: Effect modification by physical activity behaviour.Impaired telomere length and telomerase activity in peripheral blood leukocytes and granulosa cells in patients with biochemical primary ovarian insufficiency.Association of leukocyte telomere length in peripheral blood leukocytes with endometrial cancer risk in Caucasian Americans.Comparison of telomere length and insulin-like growth factor-binding protein 7 promoter methylation between breast cancer tissues and adjacent normal tissues in Turkish women.Telomere length is short in PCOS and oral contraceptive does not affect the telomerase activity in granulosa cells of patients with PCOS.Leukocyte and Skeletal Muscle Telomere Length and Body Composition in Monozygotic Twin Pairs Discordant for Long-term Hormone Replacement Therapy.Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length.
P2860
Q21090806-4DC980C5-D7B3-4F5F-B82C-D0A223B7BBABQ23910671-4C698C35-0376-4FEA-9CCC-A1177722E98CQ24652633-5F94AA08-1C07-4BDC-BF06-C1D83A1E6ED3Q28388319-7221CC49-A3A0-452B-9F8B-6D8E70955B47Q28600847-5CF339C9-66B6-481C-98CB-0B6233D5FE64Q29307230-77CBBACC-42D1-4AF4-A294-182B0DB9F5A5Q33591567-A065FA16-9BF2-4DBD-88AB-B59DCDF69C71Q33693377-8C15244E-AFE7-4CEA-BFB7-19BE31CD3017Q33818013-3D165E9B-F791-4FE0-B0FE-3909135CD1ABQ33884203-D1B01D27-999D-4856-A32B-E1552C71AFA0Q34031141-10A135AB-1258-4733-842A-F0BD82049E08Q34051060-B34B1002-6CB8-4DAE-99B1-D87D84F4453FQ34673793-14D06325-F803-4C84-9DB3-0ED6BD8B36E9Q35007976-B6DC19FC-8B23-43BC-AD30-28C241068A5CQ35067446-2BC3FAC3-AF98-465B-8420-E1DE1B65F029Q35082604-9442A766-2EC8-4917-951F-A909FE2DF789Q35084092-00ADDCDD-D5FA-4D72-B9AE-667FF3DE76A0Q35768383-72571B9F-1DB4-4404-9FB0-2F3EB6285F09Q35827999-37746A74-06EE-4896-93FC-F027DC961FD4Q35898051-B1F83002-EE44-490A-AE63-CE1387DDC11EQ35983327-9A006CC5-4830-4993-9A4A-E4C84FF4FF58Q36044945-C6139B6E-990E-4C2C-BDE7-7699A5E265F9Q36408589-B378425A-CED6-4A2B-897D-4940D3AD8870Q36422261-EFEEA0C5-BA43-4050-8CC4-7E7C3678AD4CQ36460784-E1A9287A-FE3F-451F-98D5-CAD15E8497D7Q36765175-EF7D35A3-DDB5-4F51-9CFC-34B2EEE7D3A9Q37155526-41D73736-1EDD-4491-888E-163C764D9CCEQ37431101-52EE1D63-488A-4BC9-8645-765E555741EBQ37804610-66589DC6-668B-4550-90F8-F3BBAC272F1CQ37976412-EC24CDF0-6D22-410A-9FB0-DA7DA8A932A5Q38019995-BBB1670F-3CFB-4A23-B803-3EE179028CBCQ38671524-1C35885B-2034-4AB3-A697-2D222CBD379DQ38891642-9331622C-E15F-4A48-B51F-0E5DB61D712BQ38914571-4AA80564-FFFA-4CD3-8EA8-4EEB4F0422FDQ39193908-D494F773-9E77-4B1A-B7B8-811DFCF24C11Q41344780-08F458E4-6F0F-4B70-9183-C5526064B191Q48281213-5A3A8BE4-6517-4AA3-98AF-40ED020DC0D9Q52772537-8B1CFAC8-ECB6-4923-8C5C-D8A7E1530F3CQ52908013-1D16878F-1472-4F81-BA1A-2DC7827D24DFQ53799975-EEE574AE-0020-4D88-B871-3F76FC26786E
P2860
Effect of long-term hormone therapy on telomere length in postmenopausal women.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effect of long-term hormone therapy on telomere length in postmenopausal women.
@ast
Effect of long-term hormone therapy on telomere length in postmenopausal women.
@en
type
label
Effect of long-term hormone therapy on telomere length in postmenopausal women.
@ast
Effect of long-term hormone therapy on telomere length in postmenopausal women.
@en
prefLabel
Effect of long-term hormone therapy on telomere length in postmenopausal women.
@ast
Effect of long-term hormone therapy on telomere length in postmenopausal women.
@en
P2093
P2860
P1476
Effect of long-term hormone therapy on telomere length in postmenopausal women
@en
P2093
Duk-Chul Lee
Hye-Ree Lee
Jee-Aee Im
P2860
P304
P356
10.3349/YMJ.2005.46.4.471
P577
2005-08-01T00:00:00Z